H-GADGVGKSAL-OH

Ref. 3D-PP48586

Informations sur le produit

• Nom: H-GADGVGKSAL-OH

Description

Peptide H-GADGVGKSAL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GADGVGKSAL-OH include the following: Diverse neoantigens and the development of cancer therapies RM Srivastava , TA Purohit , TA Chan - Seminars in radiation oncology, 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1053429619300761 Structural basis for T cell recognition of cancer neoantigens and implications for predicting neoepitope immunogenicity RA Mariuzza , D Wu, BG Pierce - Frontiers in Immunology, 2023 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1303304 Neoantigen T-cell receptor gene therapy in pancreatic cancer R Leidner , N Sanjuan Silva, H Huang - England Journal of , 2022 - Mass Medical Sochttps://www.nejm.org/doi/full/10.1056/NEJMoa2119662 Mutated RAS: targeting the"Untargetable" with T cells PD Chatani, JC Yang - Clinical Cancer Research, 2020 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/26/3/537/83143 Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy P Bai, Y Li, Q Zhou, J Xia, PC Wei , H Deng - , 2021 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/2162402X.2020.1868130 Characters of neoantigens in cancer immunotherapy P Bai, Y Li, Q Zhou, J Xia, M Wu, H Deng, JW Kappler - bioRxiv, 2019 - researchgate.nethttps://www.researchgate.net/profile/Philippa-Marrack/publication/334462311_Characters_of_neoantigens_in_cancer_immunotherapy/links/5f80a085a6fdccfd7b5520a6/Characters-of-neoantigens-in-cancer-immunotherapy.pdf Antigen identification for HLA class I-and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells MN Lee , M Meyerson - Science immunology, 2021 - science.orghttps://www.science.org/doi/abs/10.1126/sciimmunol.abf4001 T cell recognition of tumor neoantigens and insights into T cell immunotherapy MJW Sim , PD Sun - Frontiers in Immunology, 2022 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.833017 Systematic discovery of Neoepitope-HLA pairs for neoantigens shared among patients and tumor types HR Gurung , AJ Heidersbach, M Darwish - Nature , 2023 - nature.comhttps://www.nature.com/articles/s41587-023-01945-y Personal mutanomes meet modern oncology drug discovery and precision health F Cheng , H Liang , AJ Butte , C Eng, R Nussinov - Pharmacological reviews, 2019 - ASPEThttps://pharmrev.aspetjournals.org/content/71/1/1.abstract Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigen A Poole, V Karuppiah , A Hartt, JN Haidar - Nature , 2022 - nature.comhttps://www.nature.com/articles/s41467-022-32811-1

• Marque: Biosynth